Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2003
06/26/2003US20030119887 Lactacystin analogs
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003CA2470479A1 Polymorphs of clopidogrel hydrogensulfate
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/25/2003EP1321483A1 3,4-alkylenedioxythiophene compounds and polymers thereof
06/25/2003CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative
06/25/2003CN1112362C Preparation method of 2-thiophene ethamine
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
06/24/2003US6583089 Pre- and postemergence herbicides such as (5,5-dimethyl-1,3-dioxocyclohex-2yl)(6-methoxy-3a,4-dihydro-3H -chromeno(4,3c) isoxazolin-9-yl)methanone, formed by acylation and rearranging in the presence of catalysts
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050064A2 Mitotic kinesin inhibitors
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114480 Anellated dihydropyridines for the treatment of chronic pain
06/19/2003US20030114479 Dissolving in alcohol; mixing with antisolvent; precipitating; anticoagulants, antiischemic agents
06/19/2003US20030114437 Protease inhibitors
06/19/2003US20030114432 Antiinflammatory agents; rheumatic diseases; anticancer agents
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors
06/18/2003EP1319409A1 Solid preparations
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/17/2003US6579882 Cell adhesion-inhibiting antiinflammatory compounds
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003CA2279099C New 8h-thieno-[2,3-b]pyrrolizine-8-one derivatives, their preparation process, and pharmaceutical compositions containing these derivatives
06/17/2003CA2106966C Ionic reservoir at electrode surface
06/17/2003CA2049227C Thienopyridine derivatives, their production and use
06/17/2003CA2040606C Chiral catalysts for reduction of ketones and process for their preparation
06/12/2003WO2003048131A1 Intermediate for biotin and process for producing the same
06/12/2003US20030109542 Intermediates and methods of treating a herpesvirus infection, atherosclerosis or restenosis using such compounds or salts.
06/12/2003US20030107027 Second order nonlinear optical chromophores and electro-optic devices therefrom
06/11/2003EP1317459A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/04/2003EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof
06/04/2003CN1110494C Novel active benzothiepines having inhibitors forileal bile acid transfer and taurocholate salt adsorption
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/03/2003US6573381 Useful as intermediates, notably for the synthesis of methyl (S)-2(2-chlorophenyl)-2(4,5,6,7-tetrahydrothieno(3,2-c)-5-pyridyl)acetate or clopidrogel
06/03/2003US6573292 Treatment of Chronic Lymphocytic Leukemia and B- cell and T-cell lymphomas are provided. These methods comprise administering to a patient in need of treatment an effective amount of certain indole and carbazole compounds, such as
06/03/2003US6573268 Administering novel azolidinedione derivatives, tautomers, stereoisomers, polymorphs, pharmaceutically acceptable salts and solvates to treat diabetes
05/2003
05/30/2003WO2003044031A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
05/30/2003WO2002094187A3 Novel use
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100536 Treating a herpes virus, atherosclerosis or restenosis
05/28/2003EP1313742A1 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1313729A2 Design and synthesis of thiophene derived nlo materials for electro-optic applications
05/28/2003EP1313713A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420117A Method for preparing olanzapine
05/27/2003US6569863 Bicyclic heteroamatic compounds useful as LH agonists
05/22/2003WO2003042699A1 Tagged microparticle compositions and methods
05/22/2003WO2003042218A1 Novel compounds
05/22/2003WO2002099436A3 Characterising polypeptides
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003US20030097007 Alkylation of 3,4- dihydroxythiophene-2, 5-dicarboxylic esters or their alkali metal or alkaline earth metal salts with alkylating agents in a polar diluent in the presence of quaternary onium salts
05/22/2003US20030096994 Reacting aminobenzothiophene-3-carboxylic ester compound with nitrile compound in solution or suspension in a solvent in the presence of an acid to obtain thienopyrimidine compound
05/22/2003US20030096846 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096813 Compositions useful as inhibitors of GSK-3
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096117 Base structure is a chromene(3,2-a)fluorene ring containing spiro-fused rings; photochromic lenses; large fading rate, less color when deteriorated, and excellent light resistance in the photochromic properties
05/21/2003EP1312671A1 Magnetic particles having lower limit critical solution temperature
05/21/2003EP1311500A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity
05/21/2003EP1311487A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/21/2003EP0923581B1 4-substituted beta-carbolines as immunomodulators
05/21/2003CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound
05/21/2003CN1109037C Thicnotriazolodiazepine compounds and medical uses thereof